Chilivis Grubman LLP
  • Home
  • Firm Overview
  • Attorneys
    • Scott R. Grubman
    • Lauren A. Warner
    • Jeremy T. Berry
    • Brittany M. Cambre
    • Joseph J. Siegelman
    • Hakim Hilliard
    • Sanjay Karnik
    • Brandi Z. Murrain
    • Rachel N. Lugay
    • Maiysha Rashad
  • Practice Areas
    • Healthcare
      • Government Investigations & Litigation
      • Payor Audits and Audit Appeals
      • HIPAA and Cybersecurity
      • Medical Board Investigations
      • Peer Review & Credentialing Disputes
      • Healthcare Regulatory Compliance
    • Civil and Business Litigation
      • Class Action Defense
    • Criminal Defense
      • White Collar Crime
      • Healthcare Fraud
      • Public Corruption
      • Internal Investigations
    • False Claims Act and Qui Tam Defense
    • Data Privacy & Cybersecurity
    • Internal Investigations
    • Government Affairs
      • Advocacy and Regulatory Affairs
      • Government Contracts
      • Government Litigation and Administrative Law
      • Advertising Compliance
      • Land Use & Zoning
      • Licensing and Permits
    • Campaign Finance and Election Law
    • Entertainment Law & Artist Management
      • Trademark, Copyright, and Brand Protection
  • Blog
  • News
  • Insights
  • Contact
Select Page

Humana Agrees to Pay $90 Million to Settle False Claims Act Case

Aug 18, 2024 | False Claims Act, Health Care, Health Care Fraud, Medicare and Medicaid

On August 16, 2024, the plaintiff’s law firm Phillips & Cohen announced that health insurance giant Humana agreed to pay $90 Million to settle a qui tam whistleblower lawsuit filed under the federal False Claims Act (FCA). According to the law firm’s...

DOJ Announces Two Major FCA Settlements Involving Avoidance of Import Duties

Aug 12, 2024 | False Claims Act, federal investigations, Fraud Investigations

Last week, the DOJ announced two separate False Claims Act (FCA) settlements alleging the avoidance of import duties.  Both were the result of qui tam whistleblower lawsuits. First, on August 8, 2024, the United States Attorney’s Office for the Eastern District of...

$26M Judgment Against Lab Companies and their Owner for False Claims Act Violations

Aug 2, 2024 | False Claims Act

On July 25, 2024, the Department of Justice (DOJ) announced that the U.S. District Court for the District of Maryland awarded default judgments amounting to $26,341,951 against Patrick Britton-Harr and his laboratory companies for alleged violations of the False...

Health System Faces FCA Complaint 20 Years After Paying $40 Million to Settle Prior Alleged Violations

Aug 2, 2024 | False Claims Act

The DOJ announced that the government has filed a False Claims Act (FCA) complaint against Erlanger Health System. Defendant Chattanooga-Hamilton County Hospital Authority, doing business as Erlanger Medical Center and Erlanger Health System, operates several...

Telecommunications Company Will pay $6.5 Million to Resolve Allegations of Violating the FCA

Jul 16, 2024 | False Claims Act

The DOJ has announced that Armstrong Group, a telecommunications company based in Pennsylvania, has agreed to pay $6.5 million to resolve allegations of violating the False Claims Act (“FCA”). Armstrong Group allegedly violated the Federal Communications Commission’s...

Home Health Agencies Will Pay Over $4 Million to Resolve Allegations of Violating the FCA

Jul 10, 2024 | False Claims Act

The DOJ announced that Guardian Health Care Inc., Gem City Home Care LLC, Care Connection of Cincinnati LLC, and Evolution Health LLC (“Companies”) will pay $4,496,330 to resolve allegations of violating the False Claims Act (“FCA”). The Companies, which were...
« Older Entries
Next Entries »

Recent Posts

  • Kendrick 1, Drake 0: Federal Judge Dismisses Drake’s Claims Against Distributor Over Kendrick Lamar Diss Track
  • Medical Device Manufacturer and Distributor Pay Combined $37 Million Under False Claims Act
  • Knee Implant Manufacturer Agrees to $8 Million False Claims Act Settlement
  • Condo Conversion Planned for 2460 Peachtree Road
  • HHS-OIG Expresses “Major Concerns” About Skin Substitutes

Categories

  • A.I. Law
  • Accessory Dwelling Units
  • Administrative Law
  • Anti-Counterfeit
  • Atlanta News
  • Brand Protection
  • Business Litigation
  • Civil Healthcare Litigation
  • Civil Matters
  • Civil Rights
  • Code Enforcement
  • Commercial Litigation
  • Commercial Payor Audits
  • Complex Criminal Litigation
  • Copyright Infringement
  • COVID-19 Related Law
  • Criminal Matters
  • Cyber Law
  • Data Breach
  • Defamation
  • DMEPOS
  • DOJ
  • Drug Policy Law
  • Election Law
  • Employment Law
  • Environmental
  • False Claims Act
  • federal investigations
  • Federal Tax Investigations
  • FINRA
  • Firm Announcement
  • FOIS Compliance
  • Fraud Investigations
  • General
  • Government Affairs
  • Government Contract
  • Government Investigations
  • Government Litigation
  • Health Care
  • Health Care Fraud
  • Healthcare Transactions
  • HIPAA
  • Housing Development Law
  • Land Use Law
  • Land Zoning Law
  • Liquor Law
  • Medicare and Medicaid
  • Non-Profit Organizations
  • ommercial payor audits
  • Open Records Act
  • Overpayment Appeals
  • PPP Investigations
  • Public Corruption
  • Restrictive Covenants
  • SEC Investigations
  • Special Use Permit Filing
  • State Bar of Georgia Investigations
  • Strategic Land Use
  • Tax Fraud
  • toxic tort
  • Trade Law
  • Trademark Enforcement
  • Trademark Protection
  • Tree Ordinance
  • Uncategorized
  • Variances
  • White Collar Crime
  • Zoning and Land Use
Built by The Montgomery Group